Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2025-07-25 Annual Report
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Jaarverslag 2023.pdf
Annual Report Classification · 100% confidence The document is titled '2023' and explicitly identifies itself as a 'jaarverslag' (annual report) for Biocartis Group NV covering the period from January 1, 2023, to December 31, 2023. It contains sections on corporate governance, management reports, and financial disclosures, which are characteristic of a full annual report. Although the company notes it has ceased operations due to the 'Uitwinning van Zekerheden' (enforcement of security interests), the document serves as the formal annual financial reporting for the fiscal year. FY 2023
2025-07-25 Dutch
Uitstaande aandelen en stemrechten - Outstanding shares and voting rights.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal notification regarding the number of outstanding shares and voting rights in preparation for an upcoming Ordinary General Shareholders' Meeting. It is a regulatory disclosure required under the Belgian Code of Companies and Associations to inform shareholders of their voting power before the meeting. Since it relates to the procedural requirements for a general meeting and voting rights, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-07-25 Dutch
Convening Notice.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Convening Notice' for an Ordinary General Shareholders' Meeting. It outlines the agenda, proposed resolutions, and participation procedures for shareholders. This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2025-07-25 English
Oproeping.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official 'Oproeping Gewone Algemene Aandeelhoudersvergadering' (Notice of Ordinary General Meeting of Shareholders) for Biocartis Group NV. It outlines the agenda, voting proposals, and participation procedures for an upcoming shareholder meeting. This document is a formal solicitation of shareholder action and information for a meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-07-25 Dutch
549300J4HOJL5KG8HY54-2023-12-31-en.zip
Annual Report (ESEF) Classification · 100% confidence FY 2023
2025-07-25 English
549300J4HOJL5KG8HY54-2023-12-31-en.xhtml
Annual Report Classification · 100% confidence The document is explicitly titled 'BIOCARTIS ANNUAL REPORT 2023' and contains comprehensive sections including 'About this report', 'Corporate governance report', and detailed management discussions regarding the company's financial position, business developments, and risks. It fulfills the criteria for an annual report as it covers the full fiscal year 2023 and provides substantive financial and operational analysis. FY 2023
2025-07-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.